Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention.

Kitai Y, Ozasa N, Morimoto T, Bao B, Furukawa Y, Nakagawa Y, Kadota K, Yanagita M, Shizuta S, Kimura T; CREDO-Kyoto registry investigators.

Int J Cardiol. 2013 Oct 15;168(6):5221-8. doi: 10.1016/j.ijcard.2013.08.029. Epub 2013 Aug 16.

PMID:
23998544
2.

β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.

Ozasa N, Morimoto T, Bao B, Furukawa Y, Nakagawa Y, Kadota K, Iwabuchi M, Shizuta S, Shiomi H, Tazaki J, Natsuaki M, Kimura T; CREDO-Kyoto Registry Investigators.

Int J Cardiol. 2013 Sep 30;168(2):774-9. doi: 10.1016/j.ijcard.2012.10.001. Epub 2012 Nov 2.

PMID:
23127614

Supplemental Content

Loading ...
Support Center